Reddit Posts
Alvotech, Stada get EMA review for biosimilar to J&J's Stelara (NASDAQ:ALVO)
ALVO FDA has completed review of Alvotech's application of AVT02 as an interchangeable to high-concentration of Humira(R) and confirmed that the data provided are sufficient to support a determination of interchangeability; approval requires satisfactory outcome of upcoming facility reinspection
Mentions
$ALVO finally upgraded by MS. Highly undervalued.
ALVO’s a grrrdamn rocket today.
Why during ah ALVO? https://preview.redd.it/uzdz0x5389jf1.jpeg?width=1179&format=pjpg&auto=webp&s=62fc65945abc5a60ea495d5b8bc48ebf3733d43a
ALVO had a massive positive earnings surprise and the stock dumped 10% on open, cause, you know…making profit is bad mkay.
If you own ALVO at the recent lows tmrw should be interesting.
ALVO. Papa don’t preach. Puts.
Im going in at 170. Went in at 30 jan 2019 first and bought more in November that year. Sold all at 143. I did miss alot but I did also gain alot. Went into BABA at 89 now. Also have position in ALVO. Lets see what will happen.
There are lots of opportunities on Pharma stock investment, focusing on. Focusing on TCH seems high risk which could be high reward as well. One way for timing your investment on stock purchase, is to keep an eye on FDA and drug news, I would more focus on more established and giant Pharma e.g. like Lily rather than new ones... there is a chance their stock goes down to nearly 0 cents. e.g. look at Alvotech for example that I have been keeping an eye on for nearly 4 months, it developed a generic drug with high margin for rheumatoid diseases, stock went up a lot since the news, you could only make that gain if you are on top of all news about the company, ticker name is ALVO [https://new-medicines.com/avt02-adalimumab/](https://new-medicines.com/avt02-adalimumab/)
ALVO is really popping, too bad im yolo'd into ALCC, hope sam's dong can carry me
It is all depending on individual companies and drugs being developed rather than Biden or Trump... see this article about investing opportunities, [https://new-medicines.com/semaglutide-clinical-trials/](https://new-medicines.com/semaglutide-clinical-trials/) Lots of clinical trials are in place, imagine if **JUST ONE TRIAL is successfull** !!! the stock and revenue jump up ! regardless of Trmup or Biden |Study Title|Sponsor| |:-|:-| |Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome|University of Colorado, Denver| |Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease|Yale University| |Semaglutide in Nonalcoholic Fatty Liver Disease|Zagazig University| |Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)|Vanderbilt University Medical Center| |Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome|Peking University First Hospital| |The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure|Rigmor Højland Jensen| |Semaglutide and Vascular Regeneration|Canadian Medical and Surgical Knowledge Translation Research Group| |Pharmacogenetics of Response to GLP1R Agonists|University of Maryland, Baltimore| |Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?|Psychiatric Centre Rigshospitalet| |Semaglutide and Physical Activity for Obesity and Multimorbidity|Hvidovre University Hospital| source: [https://new-medicines.com/semaglutide-clinical-trials/](https://new-medicines.com/semaglutide-clinical-trials/) this website by the way comes up with some investment opportunities in Pharma, most of them are long-term though, so wont work as a signal for option trading, but if you are a long-term investor, you would first look at the fundamental and keep an eye on what **trial is near compltion,** there will be when everyone rushes to buy the stock, Another opportunity is NASDAQ: ALVO, they can easily dominate the market with their anti-inflammatory drug: [https://new-medicines.com/?s=alv](https://new-medicines.com/?s=alv)
I guess $ALVO is a decent successful spac
Any thoughts on a stock ALVO? I just noticed it two days ago and it seems like it’s going to pop a little.
I will look at FREY, never studied it. I dumped Sarcos Robotics and I am thinking about adding ALVO warrants after I read the SEC docs. I’m also going to dump my ARIZR, probably but it’s not a big position
Anybody else tidying up the port? I’m not really looking at Tax loss harvesting but I’m thinking about getting out of a position or two and adding some. There’s only three left that aren’t massive longevity plays. Why does MKFG look so bad right now, doesn’t Porche own a chunk of that and didn’t Tesla use it to cut costs? What’s the skinny on the dive? Pretty Green Day over all if I include sideways and .008 cent gains. 😎 even my watch list is green. Should’ve bloody well flipped Microstrategy again. It’s over 200 today and I coulda have entered at 170ish. But better safe than sorry. That ALVO is a biotech beast. Holding up well. Over 8 bucks today. Nice to see.
That ALVO looks good, with every metric other than cash to burn. But they keep getting 50 to 100 million from tutes without any meaningful dilution. Decent float.
BTMD had 1.2 million and is at $3. ALVO had 980k and dropped today. it’s just a new pattern I see. It’s better to short imo
GGPI, ALVO, DUNE, WIRE [the top socially influenced SPACs](https://swaggystocks.com/dashboard/stocks/top-spacs-list). he bot? dump eeet